跳至主要内容
临床试验/NCT00945737
NCT00945737已完成不适用

A Randomized, Controlled Parallel Study to Evaluate the Effects of a Non-Commercial Soy Protein Product on Fecal Bile Acids and Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia

Solae, LLC2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Solae, LLC
入组人数
60
试验地点
2
主要终点
The difference between treatment groups in the percent change from baseline to the end of treatment in LDL-C

研究概览

简要总结

The objectives of the trial are to determine whether a non-commercial soy protein product, consumed as part of a low-saturated fat diet, reduces low-density lipoprotein cholesterol (LDL-C) concentrations in men and women with mild to moderate hypercholesterolemia, and affects other aspects related biomarkers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female
  • •18-79 years of age
  • •Fasting LDL-Cholesterol level borderline to high range taking no cholesterol lowering medications
  • •otherwise judged to be in good health, willing to maintain a stable body weight and follow the TLC diet throughout the trial.

排除标准

  • •CHD or CHD risk equivalent
  • •Pregnancy
  • •Food allergy or sensitivity to soy or milk protein
  • •Certain muscle, liver, kidney, lung or gastrointestinal conditions and medications
  • •Poorly controlled hypertension
  • •Cancer treated within prior 2 years

研究组 & 干预措施

Soy protein

Active Comparator

干预措施: Soy protein; 25 grams/day (Dietary Supplement)

Milk protein

Placebo Comparator

干预措施: Control protein (Dietary Supplement)

结局指标

主要结局

The difference between treatment groups in the percent change from baseline to the end of treatment in LDL-C

时间窗: 4 weeks

次要结局

  • Changes in other lipid levels and other related biomarkers(4 weeks)

研究者

发起方
Solae, LLC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验